MarketInOut Stock Screener Log In | Sign Up
 

Astellas Pharma Inc

OTC • Healthcare • Drug Manufacturers - General • Quote as of 06/17/2026 14:56
Astellas Pharma Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization24,633 mln
Float1,791 mln
Earnings Date04/27/2026

EPS

1.01
Decent

P / E

13.27
Fair value

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.64
Likely reliable

Relative Strength

27 / 100
Underperforming

Debt / Equity

0.31
Low leverage

Business Description

Astellas Pharma is a Japanese pharmaceutical company founded in 1923 that develops and sells medicines across several major health areas, including cancer, kidney disease, eye conditions, and women's health. Its product portfolio includes treatments for prostate cancer, leukemia, bladder issues, menopause symptoms, and anemia, among others. The company also pursues external partnerships to expand its research capabilities, including work on next-generation RNA-based therapies and diabetes management tools.

Key Fundamentals

EPS1.01
P/E13.27
ROE17.80
RPS7.85
ROIC9.51
ROA8.42
Interest Cover26.81
EBITDA, mln3,869
EV / EBITDA6.39
EV / EBIT9.56
Revenue, mln14,100
EV / Revenue1.75

Financial Strength

Altman Z-Score2.79
Piotroski F-Score 7 / 9
Beneish M-Score-2.64
Price to Intrinsic Value0.93
Price to Lynch Fair Value1.07
Price to Graham Number2.40
Shiller PE Ratio23.31

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.23% 56 / 100   
1 Month -6.26% 39 / 100   
2 Months -19.68% 26 / 100   
6 Months 52.89% 85 / 100   
1 Year 31.92% 62 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us